Assessment of NanoString technology as a tool for profiling circulating miRNA in maternal blood during pregnancy
2024

Using NanoString Technology to Study miRNA in Maternal Blood During Pregnancy

Sample size: 12 publication 10 minutes Evidence: moderate

Author Information

Author(s): Adamova Petra, Powell Andrew K., Dykes Iain M.

Primary Institution: Liverpool John Moores University

Hypothesis

User-defined variables in NanoString nCounter analysis significantly affect the detection of circulating miRNA changes in maternal blood during pregnancy.

Conclusion

User-defined variables greatly influence the output of the NanoString nCounter assay, highlighting the need for standardized analysis methods.

Supporting Evidence

  • Thirty-one putative differentially expressed miRNAs were identified by nSolver.
  • Four miRNAs with known roles in pregnancy were validated.
  • No single nSolver analysis workflow could successfully identify all four validated changes.
  • Errors in nSolver data processing were revealed through reverse engineering.

Takeaway

This study looked at how different ways of analyzing blood samples can change the results we get about tiny molecules called miRNAs during pregnancy.

Methodology

Total RNA was prepared from maternal blood of pregnant and control rats, and miRNA expression was profiled using NanoString nCounter, followed by validation with RT-qPCR.

Potential Biases

Potential biases due to user-defined variables in data processing and analysis methods.

Limitations

The study was limited by small sample size and did not compare nCounter results with alternative methods like RNA-seq.

Participant Demographics

Twelve Wistar female rats, divided into pregnant and control groups of equal size.

Statistical Information

P-Value

0.0017

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.20517/evcna.2024.38

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication